Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 38,699Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AGILE

02 2APIL

03 1AVION PHARMS

04 8BAYER HLTHCARE

05 11MAYNE PHARMA

06 5TEVA BRANDED PHARM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ETHINYL ESTRADIOL; LEVONORGESTREL

US Patent Number : 8747888

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204017

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-07-10

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ETHINYL ESTRADIOL; LEVONORGESTREL

US Patent Number : 8246978

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204017

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-26

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ETHINYL ESTRADIOL; LEVONORGESTREL

US Patent Number : 9050348

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204017

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-07-10

blank

04

arrow
Antibody Engineering
Not Confirmed

APIL

Country
arrow
Antibody Engineering
Not Confirmed

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

US Patent Number : 7704984

Drug Substance Claim :

Drug Product Claim :

Application Number : 22501

Patent Use Code : U-1090

Delist Requested :

Patent Use Description : LO LOESTRIN FE IS INDI...

Patent Expiration Date : 2029-02-02

blank

05

arrow
Antibody Engineering
Not Confirmed

APIL

Country
arrow
Antibody Engineering
Not Confirmed

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

US Patent Number : 7704984

Drug Substance Claim :

Drug Product Claim :

Application Number : 204654

Patent Use Code : U-1

Delist Requested :

Patent Use Description : PREVENTION OF PREGNANC...

Patent Expiration Date : 2029-02-02

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ETHINYL ESTRADIOL; LEVONORGESTREL

US Patent Number : 7838042

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 208612

Patent Use Code : U-3251

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-01

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM

US Patent Number : 11617751

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22574

Patent Use Code : U-1

Delist Requested :

Patent Use Description : PREVENTION OF PREGNANC...

Patent Expiration Date : 2030-07-17

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM

US Patent Number : 11617751

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22574

Patent Use Code : U-3572

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-17

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM

US Patent Number : 11617751

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22532

Patent Use Code : U-1

Delist Requested :

Patent Use Description : PREVENTION OF PREGNANC...

Patent Expiration Date : 2030-07-17

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM

US Patent Number : 11617751

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22532

Patent Use Code : U-3572

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-17

blank